Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | AZN | AMGN | GILD | VRTX |
| Company | Repligen Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 117.77 | 69.96 | 269.48 | 105.85 | 428.68 |
| High | 118.90 | 70.60 | 272.52 | 107.84 | 436.59 |
| Low | 116.89 | 69.93 | 269.13 | 105.58 | 427.43 |
| Last | 118.15 | 70.41 | 271.66 | 107.37 | 436.00 |
| Change | -2.30 | +0.46 | -0.24 | +0.63 | +1.97 |
| % Change | -1.91% | +0.66% | -0.09% | +0.59% | +0.45% |
| Volume | 614,953 | 3,957,258 | 2,527,041 | 6,036,390 | 1,426,036 |
| 20-Day Average Volume | 842,708 | 5,254,998 | 2,922,527 | 9,002,415 | 2,148,307 |
| Previous Close | 120.45 | 69.95 | 271.90 | 106.74 | 434.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 130.24 | 69.65 | 275.46 | 103.11 | 455.39 |
| 20-Day Raw Stochastic | 4.00% | 65.08% | 33.46% | 86.50% | 20.60% |
| 20-Day Relative Strength | 40.75% | 51.57% | 43.97% | 53.76% | 40.72% |
| Weighted Alpha | -28.86 | -9.80 | -13.87 | +57.32 | -8.46 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 64% Buy | 56% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 88% Sell | 64% Buy | 56% Sell |
| Last Month's Opinion | 48% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.60% since 05/16/25 | +2.33% since 05/16/25 | -0.28% since 05/16/25 | +4.75% since 05/16/25 | -0.60% since 05/16/25 |
| Low | 116.89 on 05/23/25 | 68.68 on 05/19/25 | 269.10 on 05/22/25 | 102.84 on 05/19/25 | 427.43 on 05/23/25 |
| High | 129.42 on 05/20/25 | 70.98 on 05/21/25 | 276.90 on 05/20/25 | 109.25 on 05/20/25 | 448.00 on 05/20/25 |
| 1-Month | |||||
| %Chg | -16.44% since 04/23/25 | +2.77% since 04/23/25 | -2.25% since 04/23/25 | +0.93% since 04/23/25 | -11.46% since 04/23/25 |
| Low | 116.89 on 05/23/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 148.38 on 04/28/25 | 72.69 on 05/06/25 | 292.00 on 04/30/25 | 109.25 on 05/20/25 | 510.77 on 04/30/25 |
| 3-Month | |||||
| %Chg | -25.69% since 02/21/25 | -5.13% since 02/21/25 | -10.35% since 02/21/25 | -2.35% since 02/21/25 | -9.96% since 02/21/25 |
| Low | 102.96 on 04/07/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 168.10 on 02/24/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -17.13% since 11/22/24 | +7.28% since 11/22/24 | -7.76% since 11/22/24 | +19.05% since 11/22/24 | -3.32% since 11/22/24 |
| Low | 102.96 on 04/07/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 182.52 on 01/28/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,767,241 | 216,932,224 | 146,202,256 | 132,776,968 | 111,457,600 |
| Shares Outstanding, K | 56,183 | 3,101,247 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 634,440,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -25,510,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 169,170,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | 5,830,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 1.21 | 0.40 | 0.51 | 0.26 | 0.51 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.39 on 04/29/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 04/29/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 75.60 | 16.13 | 13.07 | 13.92 | 0.00 |